Business Segments · Selling, general and administrative expenses
MedSurg — Selling, general and administrative expenses
Boston Scientific MedSurg — Selling, general and administrative expenses decreased by 0.5% to $557M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.8%, from $512M to $557M. Over 3 years (FY 2022 to FY 2025), MedSurg — Selling, general and administrative expenses shows an upward trend with a 12.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026May 1, 2026
How to read this metric
Increasing expenses may signal investment in market expansion or rising overhead costs.
Detailed definition
Operating expenses incurred by the MedSurg segment for sales, marketing, and general administrative functions. This incl...
Peer comparison
Standard operating expense category for business segments in the medical device sector.
Metric ID:
bsx_segment_medsurg_selling_general_and_administrative_expensesHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $377.5M | $377.5M | $377.5M | $377.5M | $410.5M | $410.5M | $410.5M | $410.5M | $439M | $454M | $440M | $483M | $512M | $517M | $531M | $560M | $557M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +8.7% | +0.0% | +0.0% | +0.0% | +6.9% | +3.4% | -3.1% | +9.8% | +6.0% | +1.0% | +2.7% | +5.5% | -0.5% |
| YoY Change | — | — | — | — | +8.7% | +8.7% | +8.7% | +8.7% | +6.9% | +10.6% | +7.2% | +17.7% | +16.6% | +13.9% | +20.7% | +15.9% | +8.8% |
Range$377.5M – $560M
CAGR+10.2%
Avg YoY Growth+11.8%
Median YoY Growth+8.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's medsurg — selling, general and administrative expenses?
- Boston Scientific (BSX) reported medsurg — selling, general and administrative expenses of $557M in Q1 2026.
- How has Boston Scientific's medsurg — selling, general and administrative expenses changed year-over-year?
- Boston Scientific's medsurg — selling, general and administrative expenses increased by 8.8% year-over-year, from $512M to $557M.
- What is the long-term trend for Boston Scientific's medsurg — selling, general and administrative expenses?
- Over 3 years (2022 to 2025), Boston Scientific's medsurg — selling, general and administrative expenses has grown at a 12.0% compound annual growth rate (CAGR), from $1.51B to $2.12B.
- What does medsurg — selling, general and administrative expenses mean?
- The total operating costs for sales, marketing, and administration within the MedSurg segment.